SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-20-219417
Filing Date
2020-08-14
Accepted
2020-08-13 21:53:34
Documents
16
Period of Report
2020-08-13
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d96041d8k.htm   iXBRL 8-K 30176
2 EX-99.1 d96041dex991.htm EX-99.1 43737
3 EX-99.2 d96041dex992.htm EX-99.2 59684
8 GRAPHIC g96041g0813072937572.jpg GRAPHIC 3675
  Complete submission text file 0001193125-20-219417.txt   325089

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA amgn-20200813.xsd EX-101.SCH 4547
5 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE amgn-20200813_def.xml EX-101.DEF 13773
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE amgn-20200813_lab.xml EX-101.LAB 22821
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE amgn-20200813_pre.xml EX-101.PRE 14742
9 EXTRACTED XBRL INSTANCE DOCUMENT d96041d8k_htm.xml XML 6351
Mailing Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320
Business Address ONE AMGEN CENTER DRIVE THOUSAND OAKS CA 91320 (805)447-1000
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37702 | Film No.: 201101080
SIC: 2836 Biological Products, (No Diagnostic Substances)